Efficacy and Safety of Tofacitinib in Patients with Polymyalgia Rheumatica (EAST PMR): An open-label randomized controlled trial

BACKGROUND: Polymyalgia rheumatica (PMR) is a common inflammatory disease in elderly persons whose mechanism of pathogenesis has not been elucidated. Glucocorticoids are the main first-line treatments but result in numerous side effects. Therefore, there is a need to explore pathogenetic factors and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xinlei, Yang, Fan, Wu, Jinzhi, Xu, Bei, Jiang, Mengdi, Sun, Yiduo, Sun, Chuanying, Yu, Ye, Xu, Danyi, Xiao, Lanlan, Ren, Chunyun, Chen, Chunyan, Ye, Zi, Liang, Junyu, Lin, Jin, Chen, Weiqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309604/
https://www.ncbi.nlm.nih.gov/pubmed/37384596
http://dx.doi.org/10.1371/journal.pmed.1004249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309604/
https://www.ncbi.nlm.nih.gov/pubmed/37384596
http://dx.doi.org/10.1371/journal.pmed.1004249

Ejemplares similares